What was NeurAxis, Inc.’s price range in the past 12 months?
NeurAxis, Inc. lowest stock price was $1.80 and its highest was $6.93 in the past 12 months.
What is NeurAxis, Inc.’s market cap?
Currently, no data Available
When is NeurAxis, Inc.’s upcoming earnings report date?
NeurAxis, Inc.’s upcoming earnings report date is May 22, 2024 which is in 4 days.
How were NeurAxis, Inc.’s earnings last quarter?
NeurAxis, Inc. released its earnings results on Apr 09, 2024. The company reported -$0.816 earnings per share for the quarter, missing the consensus estimate of -$0.15 by -$0.666.
NeurAxis, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NeurAxis, Inc. have?
NeurAxis, Inc. has 6,594,897 shares outstanding.
What happened to NeurAxis, Inc.’s price movement after its last earnings report?
NeurAxis, Inc. reported an EPS of -$0.816 in its last earnings report, missing expectations of -$0.15. Following the earnings report the stock price went down -0.327%.
Which hedge fund is a major shareholder of NeurAxis, Inc.?
Currently, no hedge funds are holding shares in NRXS
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
Copying Karen Sterling's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -48.50% per trade.